Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases

NCT03818165 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Limited enrollment.

Conditions

Metastatic Pancreatic Carcinoma

Interventions

BIOLOGICAL: CAR2 Anti-CEA CAR-T cells

Sponsor

Sorrento Therapeutics, Inc.